Natale, C.; Barzago, M.M.; Colnaghi, L.; De Luigi, A.; Orsini, F.; Fioriti, L.; Diomede, L. A Combined Cell-Worm Approach to Search for Compounds Counteracting the Toxicity of Tau Oligomers In Vivo. Int. J. Mol. Sci.2022, 23, 11277.
Natale, C.; Barzago, M.M.; Colnaghi, L.; De Luigi, A.; Orsini, F.; Fioriti, L.; Diomede, L. A Combined Cell-Worm Approach to Search for Compounds Counteracting the Toxicity of Tau Oligomers In Vivo. Int. J. Mol. Sci. 2022, 23, 11277.
Natale, C.; Barzago, M.M.; Colnaghi, L.; De Luigi, A.; Orsini, F.; Fioriti, L.; Diomede, L. A Combined Cell-Worm Approach to Search for Compounds Counteracting the Toxicity of Tau Oligomers In Vivo. Int. J. Mol. Sci.2022, 23, 11277.
Natale, C.; Barzago, M.M.; Colnaghi, L.; De Luigi, A.; Orsini, F.; Fioriti, L.; Diomede, L. A Combined Cell-Worm Approach to Search for Compounds Counteracting the Toxicity of Tau Oligomers In Vivo. Int. J. Mol. Sci. 2022, 23, 11277.
Abstract
A clear relationship between the tau assemblies and toxicity has still to be established. To correlate the tau conformation with its proteotoxic effect in vivo we developed an innovative cell-worm-based approach. HEK293 cells expressing tau P301L under a tetracycline-inducible system (HEK T-Rex) were employed to produce different tau assemblies whose proteotoxic potential was evaluated using C. elegans. Lysates from cells induced for five days, significantly reduced the worm’s locomotor activity. This toxic effect was not related to the total amount of tau produced by cells or to its phosphorylation state but was related to the formation of multimeric tau assemblies, particularly tetrameric ones. We investigated the applicability of this approach for testing compounds acting against oligomeric tau toxicity, using doxycycline (Doxy) as prototype drug. Doxy affected the tau solubility and promoted the disassembly of already formed toxic aggregates in lysates of cells induced for five days. These effects translated into a dose-dependent protective action in C. elegans. These findings confirm the validity of the combined HEK T-Rex cells and C. elegans-based approach as a platform for pharmacological screening.
Keywords
tauopathy; tau protein; oligomers; proteotoxicity; C. elegans; tetracyclines.
Subject
Medicine and Pharmacology, Pharmacology and Toxicology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
,
,
*
